Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose reduction of high-dose antipsychotics and relapse in schizophrenia
jRCT1091220273Completed
- Sponsor
- Ryota Ataniya
- Start
- Jan 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial in schizophrenia, sponsored by Ryota Ataniya. Primary endpoint: Relapse after dose reduction of antipsychotics. Started Jan 2017; status: completed.
02
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT1091220273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220273.